Invasive Fungal Infection

• FDA approval · 2022-07-28
  FDA Approved: POSACONAZOLE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for posaconazole delayed-release (POSACONAZOLE DELAYED-RELEASE) from Chartwell RX, LLC, updating its…

• FDA approval · 2016-05-24
  FDA Approved: VORICONAZOLE — Original Application (Lupin Pharmaceuticals,Inc.)

  FDA approved Lupin Pharmaceuticals' generic voriconazole through an Original Application (ANDA); the product is indicated for treating invas…

• FDA approval · 2012-06-21
  FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)

  The FDA approved a supplemental application for NOXAFIL (posaconazole) from Merck Sharp & Dohme LLC, indicating an update to the NDA under t…